RS65128B1 - Jedinjenja - Google Patents

Jedinjenja

Info

Publication number
RS65128B1
RS65128B1 RS20240128A RSP20240128A RS65128B1 RS 65128 B1 RS65128 B1 RS 65128B1 RS 20240128 A RS20240128 A RS 20240128A RS P20240128 A RSP20240128 A RS P20240128A RS 65128 B1 RS65128 B1 RS 65128B1
Authority
RS
Serbia
Prior art keywords
compounds
Prior art date
Application number
RS20240128A
Other languages
English (en)
Inventor
Pamela Brown
Michael Dawson
Mona Simonovic
Steven Boakes
Esther Duperchy
Dean Rivers
Roy Lester
Scott Coleman
Original Assignee
Spero Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Spero Therapeutics Inc filed Critical Spero Therapeutics Inc
Publication of RS65128B1 publication Critical patent/RS65128B1/sr

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/60Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation occurring through the 4-amino group of 2,4-diamino-butanoic acid
    • C07K7/62Polymyxins; Related peptides
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RS20240128A 2018-06-25 2019-06-25 Jedinjenja RS65128B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862689602P 2018-06-25 2018-06-25
PCT/EP2019/066819 WO2020002325A1 (en) 2018-06-25 2019-06-25 Compounds
EP19734346.0A EP3810633B1 (en) 2018-06-25 2019-06-25 Compounds

Publications (1)

Publication Number Publication Date
RS65128B1 true RS65128B1 (sr) 2024-02-29

Family

ID=67107423

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20240128A RS65128B1 (sr) 2018-06-25 2019-06-25 Jedinjenja

Country Status (30)

Country Link
US (2) US11459357B2 (sr)
EP (2) EP3810633B1 (sr)
JP (2) JP7488774B2 (sr)
KR (1) KR20210054500A (sr)
CN (1) CN112789287B (sr)
AR (1) AR116663A1 (sr)
AU (2) AU2019294261B2 (sr)
BR (1) BR112020026663A2 (sr)
CA (1) CA3103158A1 (sr)
CO (1) CO2020016080A2 (sr)
DK (1) DK3810633T3 (sr)
EA (1) EA202092819A1 (sr)
ES (1) ES2971732T3 (sr)
FI (1) FI3810633T3 (sr)
HR (1) HRP20240028T1 (sr)
HU (1) HUE065134T2 (sr)
IL (1) IL279620A (sr)
LT (1) LT3810633T (sr)
MA (1) MA52946B1 (sr)
MD (1) MD3810633T2 (sr)
MX (1) MX2020013811A (sr)
PH (1) PH12020552240A1 (sr)
PL (1) PL3810633T3 (sr)
PT (1) PT3810633T (sr)
RS (1) RS65128B1 (sr)
SG (1) SG11202012747VA (sr)
SI (1) SI3810633T1 (sr)
UA (1) UA128162C2 (sr)
WO (1) WO2020002325A1 (sr)
ZA (1) ZA202301937B (sr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP7349773B2 (ja) * 2014-11-26 2023-09-25 スペロ・セラピューティクス・インコーポレーテッド 化合物
HRP20240028T1 (hr) * 2018-06-25 2024-03-29 Spero Therapeutics, Inc. Spojevi
WO2022098950A1 (en) 2020-11-06 2022-05-12 Spero Therapeutics, Inc. Compounds

Family Cites Families (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2128617A (en) 1982-10-06 1984-05-02 Martti Vaara Polypeptides for use in antibacterial therapy
AU7753787A (en) 1986-08-06 1988-02-24 Jean-Luc Fauchere Production of covalent-linked conjugates from an antibiotic and a non-toxic derivative of polymyxine b
US20010021697A1 (en) 1987-09-14 2001-09-13 Henning Lowenstein Methods and compositions for the treatment of mammalian infections employing medicaments comprising hymenoptera venom, proteinageous or polypeptide components thereof, or analogues of such proteinaceous or polypeptide components
TW274552B (sr) 1992-05-26 1996-04-21 Hoechst Ag
US5767068A (en) 1997-02-13 1998-06-16 Pathogenesis Corporation Pure biologically active colistin, its components and a colistin formulation for treatment of pulmonary infections
AU2004277977B2 (en) 2003-09-30 2010-10-28 Biomechanisms Inc. Compositions and methods for treating burns
US20060004185A1 (en) 2004-07-01 2006-01-05 Leese Richard A Peptide antibiotics and peptide intermediates for their prepartion
JP5226685B2 (ja) 2006-08-11 2013-07-03 ノーザン アンチバイオティクス オイ ポリミキシン誘導体およびその使用
US7807637B2 (en) 2006-08-11 2010-10-05 Northern Antibiotics Oy Polymyxin derivatives and uses thereof
US8329645B2 (en) 2008-02-08 2012-12-11 Northern Antibiotics Ltd. Polymyxin derivatives and uses thereof
FI20085469A0 (fi) 2008-02-08 2008-05-16 Northern Antibiotics Oy Polymyksiinijohdannaiset, joissa on lyhyt rasvahappohäntä, ja niiden käyttöjä
US8193148B2 (en) 2008-02-08 2012-06-05 Northern Antibiotics Ltd. Short fatty acid tail polymyxin derivatives and uses thereof
ES2334547B1 (es) 2008-09-10 2010-12-03 Universidad De Barcelona Compuestos peptidicos antibacterianos.
AR074874A1 (es) 2008-12-23 2011-02-16 Biosource Pharm Inc Composiciones antibioticas para el tratamiento de infecciones gram negativas. metodo. uso. compuesto.
CN101851270A (zh) 2009-04-03 2010-10-06 梁浩 一种多粘菌素衍生物及其制备方法
WO2010130007A1 (en) 2009-05-14 2010-11-18 Monash University Antimicrobial compounds
US8415307B1 (en) 2010-06-23 2013-04-09 Biosource Pharm, Inc. Antibiotic compositions for the treatment of gram negative infections
WO2012051663A1 (en) 2010-10-21 2012-04-26 Monash University Antimicrobial compounds
WO2012168820A1 (en) 2011-06-08 2012-12-13 Pfizer Inc. Polymyxin derivatives useful as antibacterial agents
CN103946233A (zh) 2011-11-18 2014-07-23 诺瓦克塔生物系统有限公司 多黏菌素衍生物
RU2730012C2 (ru) 2013-05-22 2020-08-14 Сперо Терапьютикс, Инк. Производные полимиксина и их применение в комбинированной терапии совместно с различными антибиотиками
ES2910072T3 (es) 2014-03-11 2022-05-11 Spero Therapeutics Inc Derivados de polimixina y su uso en terapia combinada junto con diferentes antibióticos
US10047126B2 (en) 2014-04-01 2018-08-14 Monash University Polymyxin derivatives as antimicrobial compounds
JP7349773B2 (ja) 2014-11-26 2023-09-25 スペロ・セラピューティクス・インコーポレーテッド 化合物
WO2016166103A1 (en) * 2015-04-13 2016-10-20 Xellia Pharmaceuticals Aps Polymyxin derivatives
CA3000032A1 (en) * 2015-09-29 2017-04-06 Monash University Antimicrobial polymyxin derivative compounds
HRP20240028T1 (hr) * 2018-06-25 2024-03-29 Spero Therapeutics, Inc. Spojevi
WO2020014501A1 (en) 2018-07-11 2020-01-16 Cidara Therapeutics, Inc. Compositions and methods for the treatment of bacterial infections

Also Published As

Publication number Publication date
EA202092819A1 (ru) 2021-05-21
EP3810633A1 (en) 2021-04-28
MX2020013811A (es) 2021-03-09
JP7488774B2 (ja) 2024-05-22
AU2019294261B2 (en) 2024-02-29
PT3810633T (pt) 2024-02-19
UA128162C2 (uk) 2024-04-24
EP3810633B1 (en) 2023-12-13
CN112789287B (zh) 2024-06-21
MA52946A (fr) 2021-04-28
AU2019294261A1 (en) 2021-02-04
AU2024203362A1 (en) 2024-06-06
MD3810633T2 (ro) 2024-05-31
CN112789287A (zh) 2021-05-11
ES2971732T3 (es) 2024-06-06
CO2020016080A2 (es) 2021-01-18
US20230012121A1 (en) 2023-01-12
EP4316504A3 (en) 2024-04-17
CA3103158A1 (en) 2020-01-02
HRP20240028T1 (hr) 2024-03-29
US20210246169A1 (en) 2021-08-12
PL3810633T3 (pl) 2024-04-08
PH12020552240A1 (en) 2021-08-16
EP4316504A2 (en) 2024-02-07
LT3810633T (lt) 2024-01-10
BR112020026663A2 (pt) 2021-03-23
US11459357B2 (en) 2022-10-04
ZA202301937B (en) 2023-09-27
IL279620A (en) 2021-03-01
HUE065134T2 (hu) 2024-05-28
JP2024109664A (ja) 2024-08-14
JP2021528449A (ja) 2021-10-21
WO2020002325A1 (en) 2020-01-02
SI3810633T1 (sl) 2024-04-30
DK3810633T3 (da) 2024-01-15
AR116663A1 (es) 2021-06-02
FI3810633T3 (fi) 2024-02-09
SG11202012747VA (en) 2021-01-28
KR20210054500A (ko) 2021-05-13
TW202019949A (zh) 2020-06-01
MA52946B1 (fr) 2024-03-29

Similar Documents

Publication Publication Date Title
GB201805174D0 (en) Compounds
GB202013290D0 (en) Compounds
GB201810092D0 (en) Compounds
GB201807924D0 (en) Compounds
GB201810581D0 (en) Compounds
GB201808093D0 (en) Compounds
IL279620A (en) compounds
GB201814151D0 (en) Compounds
GB201809102D0 (en) Compounds
GB201818651D0 (en) Compounds
GB201818649D0 (en) Compounds
GB201817083D0 (en) Compounds
GB201812382D0 (en) Compounds
GB201810071D0 (en) Compounds
GB201803340D0 (en) Compounds
GB201820887D0 (en) Compounds
GB201814167D0 (en) Compounds
GB201820989D0 (en) Compounds
GB201819102D0 (en) Compounds
GB201818927D0 (en) Compounds
GB201818698D0 (en) Compounds
GB201818410D0 (en) Compounds
GB201817342D0 (en) Compounds
GB201817291D0 (en) Compounds
GB201817292D0 (en) Compounds